Desloratadine 2.5 mg Reditab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Desloratadine 2.5 mg Reditab, covering 2010-07-30 to 2010-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Multi-Center, Pediatric, Open-Label, Preference Study of Desloratadine 2.5 mg Reditab (SCH34117) and Zyrtec ® 5.0 mg Chewable Tablet Medications (Study P04573) (Completed) [Phase 4]